FDA approves 'breakthrough' Parkinson's treatment led by Cleveland Clinic doctor
Posted
Daphne Graeter (via WKBN)
On Monday, Sept. 28, the U.S. Food and Drug Administration approved a new treatment that targets dopamine pathways critical to those living with the disease.
